Brennan Troyen A
Known title: EVP and Chief Medical OfficerCIK: 0001351402
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 2,179 | $220K | 4/3/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 77,960 | $7.9M | 4/1/2022 | View on chart |
| CVS | ▲ Buy | Grant | 171,944 | $0 | 2/21/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 47,937 | $4.9M | 2/3/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 47,937 | $5.3M | 2/3/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 28,159 | $1.6M | 11/1/2021 | View on chart |
| CVS | ▼ Sell | Open Market | 28,159 | $2.5M | 11/1/2021 | View on chart |
| CVS | ▼ Sell | Open Market | 1,955 | $172K | 10/26/2021 | View on chart |
| CVS | ▲ Buy | Option Exercise | 80,802 | $4.4M | 10/26/2021 | View on chart |
| CVS | ▼ Sell | Open Market | 80,802 | $7.1M | 10/26/2021 | View on chart |
| CVS | ▼ Sell | Open Market | 2,625 | $228K | 9/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.